S
SpinDiag
Develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening of infectious diseases
About SpinDiag
Spindiag GmbH is a healthcare technology company specializing in rapid point-of-care diagnostic solutions for infectious diseases. The company operates primarily in the healthcare sector, serving hospitals, clinics, and other medical facilities that require immediate and accurate testing for infectious diseases such as COVID-19. Spindiag's core product, the Rhonda PCR rapid test, provides results for up to 60 patients per device daily, enabling healthcare providers to make quick decisions about patient quarantine and treatment. The business model focuses on selling diagnostic devices and test kits to medical institutions, generating revenue through the sale of these products and associated consumables. Spindiag's market includes both public and private healthcare providers who need efficient and reliable testing solutions to manage infectious disease outbreaks. The company aims to increase patient safety while reducing healthcare costs through its innovative technology.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2016
- Headquarters
- Freiburg, Germany
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Risk Management, Biotechnology, Point of Care, Health Diagnostics, Spinout, European Health Catapult (EIT Health), European Health Catapult 2017 (EIT Health), Biotech and Pharma
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Oct 2022 | $17M | — | European Investment Bank | ↗ |
| SERIES B✓Equity / VC | May 2020 | $18M | $71M | Think.Health | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SpinDiag is 20 monthly website visits, down 94.6% over the last three months. SpinDiag's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Think.Health
Series B and later1 investor entered at this stage
European Investment Bank
Other known investors3 additional known investors
EIT Health
University of Freiburg
German Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SpinDiag on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SpinDiag’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.